<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1652-6776</journal-id>
<journal-title><![CDATA[Cuadernos Hospital de Clínicas]]></journal-title>
<abbrev-journal-title><![CDATA[Cuad. - Hosp. Clín.]]></abbrev-journal-title>
<issn>1652-6776</issn>
<publisher>
<publisher-name><![CDATA[Universidad Mayor de San Andrés, Facultad de Medicina]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1652-67762007000200018</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[¿ Cuál es su diagnóstico ?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carballo Montesinos]]></surname>
<given-names><![CDATA[Delfo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tirado]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,UMSA  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>07</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>07</month>
<year>2007</year>
</pub-date>
<volume>52</volume>
<numero>2</numero>
<fpage>104</fpage>
<lpage>106</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1652-67762007000200018&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1652-67762007000200018&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1652-67762007000200018&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[ <P align="right"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>EDUCACI&Oacute;N M&Eacute;DICA CONT&Iacute;NUA </strong></font></P>     <div align="center"><strong><font size="4" face="Verdana, Arial, Helvetica, sans-serif"> &iquest; Cu&aacute;l es su diagn&oacute;stico ? </font> </strong></div>     <P align="center"><strong><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Dr. Delfo Carballo Montesinos* Dr. Gustavo Tirado** </font></strong></P>     <div align="justify">       <p><font face="Verdana, Arial, Helvetica, sans-serif"><font size="1">* M&eacute;dico Pat&oacute;logo, Master en Anatom&iacute;a Patol&oacute;gica    <br>     ** M&eacute;dico Ur&oacute;logo </font></font></p>   <hr width="100%"> <font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>PRESENTACI&Oacute;N CL&Iacute;NICA </strong> </font> </div>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Var&oacute;n de 25 a&ntilde;os que consulta por presentar aumento del tama&ntilde;o del test&iacute;culo izquierdo. En la palpaci&oacute;n, se </font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">nota una masa nodular, de bordes bien definidos, en la mitad inferior de la g&oacute;nada. En el examen ecogr&aacute;fico se confirma la presencia de esta masa. El paciente es </font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">sometido a orquiectom&iacute;a. </font></P>     <div align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>DESCRIPCI&Oacute;N MACROSCOPICA </strong></font><font face="Verdana, Arial, Helvetica, sans-serif"></font></div>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> La pieza quir&uacute;rgica incluye test&iacute;culo, epid&iacute;dimo y cord&oacute;n esperm&aacute;tico. El test&iacute;culo mide 6,5 x 3,5 x 2 cm. En un corte sagital, se observa una masa tumoral ovoide, gris-parduzca, compacta, de 3,5 x 3 x 1,5 cm, de bordes bien defi nidos y de consistencia dura (Figuras <a href="#f1">1</a> y <a href="#f2">2</a>). El epid&iacute;dimo y el cord&oacute;n esperm&aacute;tico no muestran infiltraci&oacute;n neopl&aacute;sica. </font></P>     <div align="center"><font face="Verdana, Arial, Helvetica, sans-serif"><a name="f1"></a><img src="/img/revistas/chc/v52n2/fig_18_1.jpg" width="285" height="223"></font> </div>     ]]></body>
<body><![CDATA[<div align="center"></div>     <P align="center"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a name="f2"></a><img src="/img/revistas/chc/v52n2/fig_18_2.jpg" width="288" height="213"> </font></P>     <P align="justify"> <font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>DESCRIPCION MICROSC&Oacute;PICA </strong></font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">La masa tumoral est&aacute; formada por tejido epitelial y mesenquimal. Existen quistes de queratina, estructuras glandulares y tejido cartilaginoso maduro. Las zonas perif&eacute;ricas est&aacute;n bien delimitadas por tejido fibroconectivo denso, que separa la neoplasia del resto del test&iacute;culo. No se encuentran elementos neurobl&aacute;sticos. No se observa infi ltraci&oacute;n vascular ni penetraci&oacute;n de la t&uacute;nica albug&iacute;nea (Fig. <a href="#f3">3</a> y <a href="#f4">4</a>) </font></P>     <P align="center"><a name="f3"></a><img src="/img/revistas/chc/v52n2/fig_18_3.jpg" width="284" height="200"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> </font></P>     <P align="center"><a name="f4"></a><img src="/img/revistas/chc/v52n2/fig_18_4.jpg" width="282" height="219"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> </font></P>     <div align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>&iquest;Cu&aacute;l es su diagn&oacute;stico? </strong> </font></div>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 1.- SEMINOMA     <br>   2.- TERATOMA MADURO     <br>   3.- TUMOR DEL SENO ENDODERMICO     ]]></body>
<body><![CDATA[<br>   4.- TERATOMA INMADURO     <br>   5.- CARCINOMA EMBRIONARIO </font></P>     <P align="justify"><b><font size="4" face="Verdana, Arial, Helvetica, sans-serif"> El diagn&oacute;stico es: </font></b></P>     <div align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>TERATOMA MADURO PURO DE TESTICULO </strong> </font></div>     <P align="justify"> <font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>COMENTARIO:</strong> Los teratoma son neoplasias de c&eacute;lulas germinales que representan el 7% de todos los tumores de las g&oacute;nadas masculinas. Dependiendo del tipo de tejido del que est&aacute;n compuestos, se dividen en embrionarios y maduros. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Afectan a dos grupos de edades; uno alrededor de los dos a&ntilde;os de vida y el otro en pacientes que se encuentran entre la segunda y la cuarta d&eacute;cadas de la vida. El comportamiento biol&oacute;gico de la neoplasia es diferente en cada grupo <Sup>(1) </Sup></font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Cl&iacute;nicamente, se presentan con agradamiento del test&iacute;culo. Los pacientes postpuberales pueden debutar con met&aacute;stasis <Sup>(2)</Sup>. Usualmente, los teratomas est&aacute;n asociados con otros tumores de c&eacute;lulas germinales, como el seminoma, carcinoma embrionario y tumor del seno endod&eacute;rmico <Sup>(3) </Sup></font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> En los pacientes con teratoma maduro puro, los marcadores s&eacute;ricos son negativos, mientras que en aqu&eacute;llos en los que coexisten componentes de carcinoma embrionario pueden mostrar alfafetoprote&iacute;na elevada <Sup>(4)</Sup>. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Los teratomas maduros, generalmente son nodulares y distorcionan la t&uacute;nica albug&iacute;nea, a la que pueden penetrar. Sin embargo, son raras las extensiones extratesticulares <Sup>(5)</Sup>. La superficie de corte puede ser s&oacute;lida o qu&iacute;stica. Cuando tienen quistes, su contenido puede ser seroso, mucoide o querat&iacute;nico. Estructuras pilosas son rara vez identificadas, a diferencia de lo que ocurre en el quiste dermoide, donde son frecuentes. Los teratomas embrionarios son de aspecto encefaloide con zonas hemorr&aacute;gicas y necrosis. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Microsc&oacute;picamente, se observa que los teratomas maduros est&aacute;n formados por c&eacute;lulas y tejidos muy parecidos a los tejidos postnatales, incluyendo estructuras derivadas de las tres capas germinales. Muestran quistes querat&iacute;nicos y glandulas de tipo ent&eacute;rico y/o respiratorio. Alternativamente, pueden presentar tejido muscular liso, adiposo, focos de neuroglia y cart&iacute;lago hialino. Incluso, podr&iacute;a haber tejido &oacute;seo con m&eacute;dula incluida. En ocasiones, se observa moderada atipia y actividad mit&oacute;tica en los tejidos mesenquimal y epitelial, aunque estas caracter&iacute;sticas no permiten clasificarlos como teratomas inmaduros. </font></P>     ]]></body>
<body><![CDATA[<P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> Este &uacute;ltimo necesariamente debe tener tejido embrionario. w </font></P>     <div align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Inmunohistoqu&iacute;mica </strong> </font></div>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> La alfafetoprote&iacute;na <Sup>(4)</Sup> y la alfa-1-antitripsina <Sup>(6)</Sup> son positivas a nivel de los epitelios ent&eacute;rico y respiratorio. La fosfatasa alcalina placentaria es positiva en el 10 al 20% de los casos <Sup>(7, 8)</Sup>. El estroma es positivo para vimentina y ocasionalmente para marcadores musculares. La prote&iacute;na 53 y el gen del retinoblastoma se puede expresar en algunos teratomas maduros e inmaduros <Sup>(9,10) </Sup></font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Frecuentemente, estas neoplasias tienen ADN aneuploide o hipotripoidia <Sup>(11)</Sup>. Este hecho soporta la opini&oacute;n de que el teratoma maduro postpuberal es maligno, a pesar de su aspecto histol&oacute;gico de aspecto benigno. La transformaci&oacute;n a un teratoma de alto grado puede ser su tendencia inherente, que se expresa con altos &iacute;ndices de met&aacute;stasis. </font></P>     <P align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El quiste dermoide, aunque es una neoplasia derivada de c&eacute;lulas germinales, no debe confundirse con el teratoma maduro y debe clasificarse en una categor&iacute;a diferente, debido a su comportamenito benigno.<Sup>(12) </Sup>    <br>   Dixon y Nmoore <Sup>(2)</Sup> han identificado diseminaci&oacute;n local en el 6% y met&aacute;stasis en el 24% de los teratomas maduros. Las met&aacute;stasis afectan, sobretodo, a los ganglios linf&aacute;ticos paraa&oacute;rticos e iliacos, h&iacute;gado, pulmones, hueso, pleura e intestinos. El aspecto histol&oacute;gico de las met&aacute;stasis puede ser diferente al tumor primario. <Sup>(13,14,15). </Sup></font></P>     <P align="justify"> <font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>REFERENCIAS </strong></font></P>     <div align="justify">       <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 1. Ulbright T. Testicular and paratesticular tumours. En Mills SE ed. Sternberg&acute;s Diagnostic Surgical Pathology, Fourth Ed, Philadelphia, Lippincott Williams &amp;Wilkins, 2004: 2188-2191.</font></p>       <!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Ulbright T. Tumors of the testis, adnexa, spermatic cord and scrotum. En Atlas of Tumor Pathology, Third series, Fascicle 25. Washigton DC. Armed Forces Institute of Pathology, 2001</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176887&pid=S1652-6776200700020001800002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Brosman SA. Testicular tumors in prepubertal children. Urology 1979;13:581-8.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176888&pid=S1652-6776200700020001800003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Jacobsen GK, Jacobsen M. Alpha- fetoprotein (AFP) and human chorionic gonadotropin in testicular germ cell tumours: a prospective immunohistochemical study. Acta Pathol Microbiol Scand [A] 1983;91:165-76.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176889&pid=S1652-6776200700020001800004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Comiter CV, Kibel AS, Richie JP, Nucci MR, Renshaw AA. Prognosticfeatures of teratomas with malignant transformation: a clinicopathologic study of 21 cases. J Urol 1998;159:359-63.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176890&pid=S1652-6776200700020001800005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Jacobsen GK, Jacobsen M, Clausen PP. Distribution of tumor- associated antigens in the various histologic components of germ cell tumors of the testis. Am J Surg Pathol 1981;5:257-66.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176891&pid=S1652-6776200700020001800006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Manivel JC, Jessurun J, Wick MR, Dehner LP. Placental alkaline phosphatase immunoreactivity in testicular germ cell tumors. Am J Surg Pathol 1987;11:21-9.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176892&pid=S1652-6776200700020001800007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Uchida T, Shimoda T, Miyata H, et al. Immunoperoxidase study of alkaline phosphatase in testicular tumor. Cancer 1981;48:1455-62.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176893&pid=S1652-6776200700020001800008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Bartkova J, Bartek J, Lukas J, et al. p53 protein alterations in human testicular cancer including pre- invasive intratubular germ- cell neoplasia. Int J Cancer 1991;49:196-202.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176894&pid=S1652-6776200700020001800009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Strohmeyer T, Reissmann P, Cordon- Cardo C, Hartmann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Nat Acad Sci USA 1991;88:6662-6.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176895&pid=S1652-6776200700020001800010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Oosterhuis JW, de Jong B, Cornelisse CJ, et al. Karyotyping and DNA flow cytometry of mature residual teratoma after intensive chemotherapy of disseminated nonseminomatous germ cell tumor of the testis: a report of two cases. Cancer Genet Cytogenet 1986;22:149-57.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176896&pid=S1652-6776200700020001800011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Price EB Jr. Epidermoid cysts of the testis: a clinical and pathologic analysis of 69 cases from the testicular tumor registry. J Urol 1969;102:708-13.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176897&pid=S1652-6776200700020001800012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Donohue JP, Roth LM, Zachary JM, Rowland RG, Einhorn LH, Williams SD. Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy. J Urol 1982;127:1111-4.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176898&pid=S1652-6776200700020001800013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Foss&auml; SD, Aass N, Ous S, et al. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J Urol 1989;142:1239-42.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176899&pid=S1652-6776200700020001800014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Foster RS, Baniel J, Leibovitch I, et al. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer. J Urol 1996;155:1943-5.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1176900&pid=S1652-6776200700020001800015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ulbright]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Testicular and paratesticular tumours]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Mills]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<source><![CDATA[Sternberg´s Diagnostic Surgical Pathology]]></source>
<year>2004</year>
<edition>Fourth</edition>
<page-range>2188-2191</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams y Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ulbright]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tumors of the testis, adnexa, spermatic cord and scrotum]]></article-title>
<source><![CDATA[Atlas of Tumor Pathology]]></source>
<year>2001</year>
<publisher-loc><![CDATA[Washigton DC ]]></publisher-loc>
<publisher-name><![CDATA[Armed Forces Institute of Pathology]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brosman]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Testicular tumors in prepubertal children]]></article-title>
<source><![CDATA[Urology]]></source>
<year>1979</year>
<volume>13</volume>
<page-range>581-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacobsen]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobsen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Alpha- fetoprotein (AFP) and human chorionic gonadotropin in testicular germ cell tumours: a prospective immunohistochemical study]]></article-title>
<source><![CDATA[Acta Pathol Microbiol Scand [A]]]></source>
<year>1983</year>
<volume>91</volume>
<page-range>165-76</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Comiter]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
<name>
<surname><![CDATA[Kibel]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Richie]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Nucci]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Renshaw]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prognosticfeatures of teratomas with malignant transformation: a clinicopathologic study of 21 cases]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>1998</year>
<volume>159</volume>
<page-range>359-63</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacobsen]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobsen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Clausen]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Distribution of tumor- associated antigens in the various histologic components of germ cell tumors of the testis]]></article-title>
<source><![CDATA[Am J Surg Pathol]]></source>
<year>1981</year>
<volume>5</volume>
<page-range>257-66</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manivel]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Jessurun]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wick]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Dehner]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Placental alkaline phosphatase immunoreactivity in testicular germ cell tumors]]></article-title>
<source><![CDATA[Am J Surg Pathol]]></source>
<year>1987</year>
<volume>11</volume>
<page-range>21-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uchida]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Shimoda]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Miyata]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Immunoperoxidase study of alkaline phosphatase in testicular tumor]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>1981</year>
<volume>48</volume>
<page-range>1455-62</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bartkova]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bartek]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lukas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[p53 protein alterations in human testicular cancer including pre- invasive intratubular germ- cell neoplasia]]></article-title>
<source><![CDATA[Int J Cancer]]></source>
<year>1991</year>
<volume>49</volume>
<page-range>196-202</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strohmeyer]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Reissmann]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cordon- Cardo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hartmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ackermann]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Slamon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Correlation between retinoblastoma gene expression and differentiation in human testicular tumors]]></article-title>
<source><![CDATA[Proc Nat Acad Sci USA]]></source>
<year>1991</year>
<volume>88</volume>
<page-range>6662-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oosterhuis]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[de Jong]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cornelisse]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Karyotyping and DNA flow cytometry of mature residual teratoma after intensive chemotherapy of disseminated nonseminomatous germ cell tumor of the testis: a report of two cases]]></article-title>
<source><![CDATA[Cancer Genet Cytogenet]]></source>
<year>1986</year>
<volume>22</volume>
<page-range>149-57</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Price]]></surname>
<given-names><![CDATA[EB Jr.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidermoid cysts of the testis: a clinical and pathologic analysis of 69 cases from the testicular tumor registry]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>1969</year>
<volume>102</volume>
<page-range>708-13</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donohue]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Roth]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Zachary]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Rowland]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Einhorn]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>1982</year>
<volume>127</volume>
<page-range>1111-4</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fossä]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Aass]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ous]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>1989</year>
<volume>142</volume>
<page-range>1239-42</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foster]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Baniel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Leibovitch]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>1996</year>
<volume>155</volume>
<page-range>1943-5</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
